Search Results 1041-1050 of 21702 for Inhibition
Concurrent use of moderate to strong CYP3A4 inhibitors is not allowed. More information. Publications. Publications are currently not available. Additional ...
Angiotensin-converting enzyme inhibitors. Also called ACE inhibitors, these medicines widen blood vessels to lower blood pressure. They can improve blood ...
We found that neuron populations undergo dynamic patterns of excitation and inhibition during stimulation and visual processing. In addition, we identified ...
Previous treatment with a Protein Kinase C (PKC) inhibitor * Concurrent malignant disease * Active HIV infection or Hep B/C * Malabsorption disorder * ...
Current use of strong CYP3A4 inducers or inhibitors NOTE: patients may ... inhibitor; Current use of thienopyridine therapy (clopidogrel, prasugrel, or ...
Patients must not have received prior exposure to TRK inhibitors ... Patients currently receiving a strong CYP3A4 inducer or inhibitor are not eligible.
Patients must not be on warfarin, strong cytochrome P450 (CYP) 3A4 inducers, strong CYP3A4 inhibitors, or strong UGT1A1 inhibitors. Note: Discontinue at ...
These patients will be on stable doses of optimized medications (including β-blockers, angiotensin-converting enzyme inhibitors or angiotensin receptor ...
Current treatment with Tamoxifen or Aromatase Inhibitors; Medical comorbidities making surgery unsafe as determined by the patient's surgeon; Women who are ...
This medicine is a MAO-B inhibitor that works to increase and extend the ... John's wort, other MAO inhibitors (MAOI) (eg, isocarboxazid, linezolid ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.